INDP

NASDAQ open

Indaptus Therapeutics

2.83 USD
▼-0.30-9.58%
盘后 3.30 0.00%
2026-11-20
市值
$433.10M
市盈率
—
EPS
-0.20
股息率
—
52 周区间
0.92 – 5.96
成交量
192.39K
Beta
0.94
目标价
—
52W 低 0.9252W 高 5.96
价格走势

公司简介

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and ...